Drug Delivery

(Image: Getty/rawpixel)

AAPS PharmSci 360: Quotes that carry

By Maggie Lynch

This week in-PharmaTechnologist attended AAPS PharmSci360 in Washington, D.C. where discussions and thought-provoking ideas bounced across sessions – here, we highlight some of the most significant.

(Image: Getty/Victor_Tongdee)

Ketamine: The future treatment of severe mental illness?

By Maggie Lynch

In this first part of a two-part investigation, we look at how NDMA receptor antagonists, such as ketamine, could be poised to make a breakthrough in the treatment of depression – an area where the pharma industry has struggled to identify new targets...

Ravikumar Majeti, Ph.D. is a professor of pharmaceutical sciences at the Texas A&M Irma Lerma Rangel College of Pharmacy, and his team at work in his lab. (Image: Texas A&M Health Science Center)

Pharmacy researchers work to improve drug delivery

By Melissa Fassbender

Researchers suggest targeted nanosystem drug delivery could be the key to crossing gastrointestinal tract and blood-brain barriers – a prevailing issue with oral medications.

Drug delivery news round up featuring Amylin, Zogenix, and more

Round up of drug delivery news

By Nick Taylor

in-PharmaTechnologist.com presents a roundup of drug delivery news, including a FDA set back at Amylin and expansion at Particle Sciences.

Spotlight

Follow us

Products

View more

Webinars

Featured Suppliers

All